Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to -$278575.0.

  • Dare Bioscience's Free Cash Flow rose 9558.35% to -$278575.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year increase of 3168.75%. This contributed to the annual value of $4.7 million for FY2024, which is 11177.87% up from last year.
  • As of Q3 2025, Dare Bioscience's Free Cash Flow stood at -$278575.0, which was up 9558.35% from -$5.6 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Free Cash Flow ranged from a high of $12.6 million in Q2 2024 and a low of -$16.1 million during Q1 2023
  • Moreover, its 5-year median value for Free Cash Flow was -$6.6 million (2023), whereas its average is -$4.9 million.
  • In the last 5 years, Dare Bioscience's Free Cash Flow surged by 55440.19% in 2022 and then tumbled by 19357.19% in 2023.
  • Quarter analysis of 5 years shows Dare Bioscience's Free Cash Flow stood at -$9.9 million in 2021, then surged by 40.51% to -$5.9 million in 2022, then crashed by 48.94% to -$8.8 million in 2023, then surged by 158.72% to $5.2 million in 2024, then plummeted by 105.4% to -$278575.0 in 2025.
  • Its last three reported values are -$278575.0 in Q3 2025, -$5.6 million for Q2 2025, and -$5.7 million during Q1 2025.